There has been a dramatic increase in knowledge about the role of aldosterone and mineralocorticoid receptor (MR) antagonists (MRAs) in the pathophysiology of cardiovascular diseases in recent years [40]. Here, NR3C2 is linked to cardiovascular disorder.